Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ADP + dithiothreitol
2'-dADP + oxidized dithiothreitol + H2O
-
-
-
?
CDP + dithiothreitol
2'-dCDP + oxidized dithiothreitol + H2O
-
-
-
?
GDP + thioredoxin
2'-deoxyGDP + thioredoxin disulfide + H2O
-
-
-
?
ribonucleoside diphosphate + thioredoxin
2'-deoxyribonucleoside diphosphate + thioredoxin disulfide + H2O
-
-
-
?
ADP + thioredoxin
2'-dADP + thioredoxin disulfide + H2O
-
-
-
-
?
CDP + thioredoxin
2'-dCDP + thioredoxin disulfide + H2O
-
CDP is the favored substrate. However, the kcat/Km values for ADP, GDP, and UDP are within 100-fold of the value for CDP
-
-
?
GDP + thioredoxin
2'-dGDP + thioredoxin disulfide + H2O
-
-
-
-
?
nucleoside 5'-diphosphate + glutaredoxin
2'-deoxynucleoside 5'-diphosphate + glutaredoxin disulfide + H2O
-
class Ia RNRs
-
-
?
nucleoside 5'-diphosphate + thioredoxin
2'-deoxynucleoside 5'-diphosphate + thioredoxin disulfide + H2O
-
class Ia RNRs
-
-
?
ribonucleoside diphosphate + reduced thioredoxin
2'-deoxyribonucleoside diphosphate + oxidized thioredoxin + H2O
UDP + thioredoxin
2'-dUDP + thioredoxin disulfide + H2O
-
-
-
-
?
additional information
?
-
ribonucleoside diphosphate + reduced thioredoxin
2'-deoxyribonucleoside diphosphate + oxidized thioredoxin + H2O
-
-
-
ir
ribonucleoside diphosphate + reduced thioredoxin
2'-deoxyribonucleoside diphosphate + oxidized thioredoxin + H2O
-
-
-
ir
ribonucleoside diphosphate + reduced thioredoxin
2'-deoxyribonucleoside diphosphate + oxidized thioredoxin + H2O
-
maximal activity with E. coli thioredoxin
-
ir
ribonucleoside diphosphate + reduced thioredoxin
2'-deoxyribonucleoside diphosphate + oxidized thioredoxin + H2O
-
enzyme catalyzes the first unique step in DNA synthesis
-
?
additional information
?
-
-
DNA damage checkpoints modulate RNR activity through the temporal and spatial regulation of its subunits
-
-
?
additional information
?
-
-
under normal conditions, the cell assembles stoichiometric amounts of tyrosyl radicals essential for enzyme activity per betabeta subunit dimer. Modulation of tyrosyl radical concentration is not involved in regulation of enzyme activity
-
-
?
additional information
?
-
-
class Ia RNRs convert nucleoside diphosphates into 2'-deoxynucleoside diphosphates using glutaredoxin or thioredoxin as cofactor
-
-
?
additional information
?
-
-
C-terminus of one monomeric R1 subunit acts in trans to regenerate the active site of its neighboring monomer. The class I RNR active-site disulfide bridge between Cys225 and Cys462 must be reduced for a complete turnover. The electron required for this reduction is provided by a redox network, which involves a cysteine pair at the C-terminus of the R1 subunit, the thioredoxin or glutaredoxin system, and NADPH. For in vitro experiments, the disulfide bridge can be reduced by small thiol compounds such as DTT
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
dATP
-
binding of deoxynucleoside triphosphate effectors ATP/dATP, dGTP, and dTTP modulates the specificity of class I ribonucleotide reductase for CDP, UDP, ADP, and GDP substrates. dNTP effectors and NDP substrates bind on either side of a flexible nine-amino acid loop.. The unprotonated N1 of adenosine is the primary determinant of ATP/dATP-directed specificity for CDP. Interactions with the effector nucleobase alter loop 2 geometry, resulting in changes in specificity among the four NDP substrates of ribonucleotide reductase
dCTP
-
stimulation of UDP reduction
phosphate
-
50 mM, slight stimulation, inhibition at 200 mM
ATP
-
-
ATP
-
binding of deoxynucleoside triphosphate effectors ATP/dATP, dGTP, and dTTP modulates the specificity of class I ribonucleotide reductase for CDP, UDP, ADP, and GDP substrates. dNTP effectors and NDP substrates bind on either side of a flexible nine-amino acid loop. The unprotonated N1 of adenosine is the primary determinant of ATP/dATP-directed specificity for CDP. Interactions with the effector nucleobase alter loop 2 geometry, resulting in changes in specificity among the four NDP substrates of ribonucleotide reductase
dGTP
-
stimulation of tubercidin diphosphate reduction
dGTP
-
binding of deoxynucleoside triphosphate effectors ATP/dATP, dGTP, and dTTP modulates the specificity of class I ribonucleotide reductase for CDP, UDP, ADP, and GDP substrates. dNTP effectors and NDP substrates bind on either side of a flexible nine-amino acid loop. The O6 and protonated N1 of dGTP direct specificity for ADP. Interactions with the effector nucleobase alter loop 2 geometry, resulting in changes in specificity among the four NDP substrates of ribonucleotide reductase
dTTP
-
stimulation of UDP reduction
dTTP
-
stimulation of CDP reduction
dTTP
-
stimulation of purine riboside diphosphate reduction
dTTP
-
stimulation of 2,6-diaminopurine riboside reduction
dTTP
-
stimulation of 2-aminopurineriboside diphosphate reduction
dTTP
-
stimulation of benzimidazoleriboside diphosphate reduction
dTTP
-
binding of deoxynucleoside triphosphate effectors ATP/dATP, dGTP, and dTTP modulates the specificity of class I ribonucleotide reductase for CDP, UDP, ADP, and GDP substrates. dNTP effectors and NDP substrates bind on either side of a flexible nine-amino acid loop. Interactions with the effector nucleobase alter loop 2 geometry, resulting in changes in specificity among the four NDP substrates of ribonucleotide reductase
additional information
-
overview: stimulation of various enzymes
-
additional information
-
stimulation by effector nucleotides
-
additional information
-
stimulation with various substrates
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
alpha subunit, in apo form, in complex with AMP analogue 5'-adenylyl-beta,gamma-imidodiphosphate, with 5'-adenylyl-beta,gamma-imidodiphosphate and CDP, with 5'-adenylyl-beta,gamma-imidodiphosphate and UDP, with dGTP and ADP, TTP and GDP. Binding of specificity effector rearranges loop 2 and moves residue P294 out of the catalytic site, accomodating substrate binding. substrate binding further rearranges loop2. Cross-talk occurs largely through R293 and Q288 of loop 2. Substrate ribose binds with its 3 hydroxyl closer than its 2 hydroxyl to residue C218 of the catalytic redox pair
purified enzyme, formed by recombinant subunits R2 and R4, complexed with inhibitor peptide P7 or peptide Fmoc-P6, 20 mg/ml protein in 0.1 M HEPES, pH 7.5, with 20 mM TTP, 5% glycerol, 5mM DTT, 0.1 M KCL, and 25 mm MgCl2, is mixed with a reservoir solution containing 20-25% PEG 3350, 0.2 M NaCl, and 100 mM HEPES, pH 7.5, soaking of crystals for 4 h in reservoir solution with added inhibitor peptide P6 or P7, followed by soaking of crystals in 25% PEG 3350, 0.2 M NaCl, and 100 mM HEPES, pH 7.5, supplemented with 15% glycerol, X-ray diffraction structure determination and analysis at 2.6 and 2.5 A resolution, respectively
structures of mutanr R293A complexed with dGTP and AMPPNP-CDP reveal that ADP is not bound at the catalytic site, and CDP binds farther from the catalytic site compared to wild type
subunit Rnr1 in complex with gemcitabine diphosphate or with a beta subunit Rnr2 or Rnr4 derived peptide. Binding of gemcitabine diphosphate is different from binding of its analogue CDP. Rnr2 and Rnr4 peptides bind differently from each other and block the formation of the enzyme complex
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Q288A
mutation causes severe S phase defects in cells that use the enzyme as the sole source of of ribonucleoside diphosphate activity. Compared to the wild-type enzyme activity, Q288A mutants show 15% of ADP reduction, whereas they show 23% of CDP reduction. There is a 6fold loss of affinity for ADP binding and a 2fold loss of affinity for CDP. Q288A can support mitotic growth, albeit with a severe S phase defect
R293A
mutation causes lethality in cells that use the enzyme as the sole source of ribonucleoside diphosphate activity. Compared to the wild-type enzyme activity, R293A mutants show 4% of ADP reduction, whereas they show 20% CDP reduction. The mutant is unable to bind ADP and binds CDP with 2fold lower affinity compared to wild-type. X-ray structures of R293A complexed with dGTP and AMPPNP reveal that ADP is not bound at the catalytic site, and CDP binds farther from the catalytic site compared to wild type. R293A cannot support mitotic growth
C428S
-
mutantion is lethal. Cells carrying both the C428S and the SX2S mutation of CX2C motif on plasmids are viable and form colonies with an efficiency similar to that of the wild-type control showing interallelic complementation
K387N
-
affords higher activity due to increased tyrosyl radical content
additional information
construction of heterochimeric enzymes as heterocomplexes containing mammalian R2 C-terminal heptapeptide P7, Ac-1FTLDADF7, and its peptidomimetic P6, 1Fmoc(Me)PhgLDChaDF7, bound to Saccharomyces cerevisiae R1, ScR1, overview
additional information
-
construction of heterochimeric enzymes as heterocomplexes containing mammalian R2 C-terminal heptapeptide P7, Ac-1FTLDADF7, and its peptidomimetic P6, 1Fmoc(Me)PhgLDChaDF7, bound to Saccharomyces cerevisiae R1, ScR1, overview
additional information
-
deletion of C-terminal domain of subunit R1 is lethal. Mutation of CX2C motif to SX2S results in viable, but slowly growing cells. Mutant cells exhibit a prolonged S phase
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Lammers, M.; Follmann, H.
The ribonucleotide reductases - a unique group of metalloenzymes essential for cell proliferation
Struct. Bonding
54
27-91
1983
Tequatrovirus T4, Tequintavirus T5, Enterobacteria phage T6, Bos taurus, Saccharomyces cerevisiae, Oryctolagus cuniculus, Escherichia coli, Homo sapiens, Mesocricetus auratus, Mus musculus, Rattus norvegicus, Tetradesmus obliquus
-
brenda
Vitols, E.; Bauer, V.A.; Stanbrough, E.C.
Ribonucleotide reductase from Saccharomyces cerevisiae
Biochem. Biophys. Res. Commun.
41
71-77
1970
Saccharomyces cerevisiae, Herpes simplex virus
brenda
Nguyen, H.H.T.; Ge, J.; Perlstein, D.L.; Stubbe, J.
Purification of ribonucleotide reductase subunits Y1, Y2, Y3, and Y4 from yeast: Y4 plays a key role in diiron cluster assembly
Proc. Natl. Acad. Sci. USA
96
12339-12344
1999
Saccharomyces cerevisiae
brenda
Yao, R.; Zhang, Z.; An, X.; Bucci, B.; Perlstein, D.L.; Stubbe, J.; Huang, M.
Subcellular localization of yeast ribonucleotide reductase regulated by the DNA replication and damage checkpoint pathways
Proc. Natl. Acad. Sci. USA
100
6628-6633
2003
Saccharomyces cerevisiae
brenda
Perlstein, D.L.; Ge, J.; Ortigosa, A.D.; Robblee, J.H.; Zhang, Z.; Huang, M.; Stubbe, J.
The active form of the Saccharomyces cerevisiae ribonucleotide reductase small subunit is a heterodimer in vitro and in vivo
Biochemistry
44
15366-15377
2005
Saccharomyces cerevisiae
brenda
Ortigosa, A.D.; Hristova, D.; Perlstein, D.L.; Zhang, Z.; Huang, M.; Stubbe, J.
Determination of the in vivo stoichiometry of tyrosyl radical per betabeta in Saccharomyces cerevisiae ribonucleotide reductase
Biochemistry
45
12282-12294
2006
Saccharomyces cerevisiae
brenda
Xu, H.; Faber, C.; Uchiki, T.; Fairman, J.W.; Racca, J.; Dealwis, C.
Structures of eukaryotic ribonucleotide reductase I provide insights into dNTP regulation
Proc. Natl. Acad. Sci. USA
103
4022-4027
2006
Saccharomyces cerevisiae (P21524)
brenda
Xu, H.; Faber, C.; Uchiki, T.; Racca, J.; Dealwis, C.
Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly
Proc. Natl. Acad. Sci. USA
103
4028-4033
2006
Saccharomyces cerevisiae (P21524)
brenda
Zhang, Z.; Yang, K.; Chen, C.C.; Feser, J.; Huang, M.
Role of the C terminus of the ribonucleotide reductase large subunit in enzyme regeneration and its inhibition by Sml1
Proc. Natl. Acad. Sci. USA
104
2217-2222
2007
Saccharomyces cerevisiae, Escherichia coli
brenda
Xu, H.; Fairman, J.W.; Wijerathna, S.R.; Kreischer, N.R.; LaMacchia, J.; Helmbrecht, E.; Cooperman, B.S.; Dealwis, C.
The structural basis for peptidomimetic inhibition of eukaryotic ribonucleotide reductase: a conformationally flexible pharmacophore
J. Med. Chem.
51
4653-4659
2008
Saccharomyces cerevisiae (P21524), Saccharomyces cerevisiae
brenda
Holmgren, A.; Sengupta, R.
The use of thiols by ribonucleotide reductase
Free Radic. Biol. Med.
49
1617-1628
2010
Saccharomyces cerevisiae, Escherichia coli, Homo sapiens, Lactobacillus leichmannii, Mus musculus
brenda
Ahmad, M.F.; Kaushal, P.S.; Wan, Q.; Wijerathna, S.R.; An, X.; Huang, M.; Dealwis, C.G.
Role of arginine 293 and glutamine 288 in communication between catalytic and allosteric sites in yeast ribonucleotide reductase
J. Mol. Biol.
419
315-329
2012
Saccharomyces cerevisiae (P21524)
brenda
Mazumder, A.; Tummler, K.; Bathe, M.; Samson, L.D.
Single-cell analysis of ribonucleotide reductase transcriptional and translational response to DNA damage
Mol. Cell. Biol.
33
635-642
2013
Saccharomyces cerevisiae
brenda
Knappenberger, A.J.; Ahmad, M.F.; Viswanathan, R.; Dealwis, C.G.; Harris, M.E.
Nucleoside analogue triphosphates allosterically regulate human ribonucleotide reductase and identify chemical determinants that drive substrate specificity
Biochemistry
55
5884-5896
2016
Saccharomyces cerevisiae, Homo sapiens (P23921), Homo sapiens (P23921 and P31350), Homo sapiens
brenda